Over the Counter (OTC) Drugs/Dietary Supplements Market Outlook and Opportunities in Grooming Regions
                     OTC Drugs & Dietary Supplements Market 
to Expand in Size by Highest Revenue up 
to 2026, Claims AMR
Over the Counter (OTC) Drugs & Dietary Supplements Market by Category (Vitamin and Dietary Supplements, Cough & Cold Products, Analgesics, 
Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Botanicals, Antacids, Smoking 
Cessation Products, Feminine Care, and Others), Dosage Form (Tablets, Hard Capsules, Powders, Ointments, Soft Capsules, Liquids, and Others), 
Product (Branded, and Generic Drugs), and Distribution Channel [Pharmacies, Grocery Stores, Vitamin and Health Food Stores, Online Pharmacies, 
and Others] - Global Opportunity Analysis and Industry Forecast, 2018-2026
Why Allied Market Research?
FREQUENTLY ASKED QUESTIONS?
INFALLIBLE METHODOLOGY
To ensure high-level data integrity, accurate analysis, and 
impeccable forecasts Q1. What is the total market value of Over the 
Counter (OTC) Drugs & Dietary Supplements 
ANALYST SUPPORT Market report?
For complete satisfaction Q2. What would be forecast period in the 
market report?
CUSTOMIZATION
Q3. What is the market value of Over the 
On-demand customization of scope of the report to exactly meet Counter (OTC) Drugs & Dietary Supplements 
your needs Market in 2020?
TARGETED MARKET VIEW Q4. Which is base year calculated in the Over 
the Counter (OTC) Drugs & Dietary 
Targeted market view to provide pertinent information and save Supplements Market report?
time of readers
Q5. Which are the top companies hold the 
market share in Over the Counter (OTC) Drugs 
& Dietary Supplements Market?
Overview
According to a new report published by Allied Market 
Research, titled, Over the Counter (OTC) Drugs & Dietary 
Supplements Market by Category, Dosage Form, Product, and 
Distribution Channel: Global Opportunity Analysis and 
Industry Forecast, 2017-2023," the global over the counter 
(OTC) drugs & dietary supplements market was valued at 
$223 million in 2016, and is projected to reach $335 million 
by 2023, growing at a CAGR of 5.9% from 2017 to 2023. The 
vitamins and dietary supplements (VDS) segment accounted 
for maximum share of about half the global market share in 
2016.
The global market is driven by improvement in lifestyle & 
ageing of baby boomers, rise in awareness about general 
health concerns, and increase in trend among individuals to 
opt for OTC drugs for self-medication. 
Segments
In terms of revenue, the global surgical robotics market is segmented on 
the basis of Category, Dosage Form, Product, Distribution Channel End 
User. 
By Product - The cough & cold products segment is expected to grow at a 
robust CAGR of 6.1% from 2017 to 2023, owing to blockbuster sales of 
these drugs. As cold & cough is the most commonly acquired ailment 
among all age groups across the globe, the sales of OTC drugs has 
increased in the recent years. Gastrointestinal products are the attractive 
segment due to increased OTC drug sales for treating gastrointestinal 
disorders such as diarrhea, constipation, indigestion, bouts of vomiting 
among others.
The tablets segment generated the highest revenue in 2016, accounting 
for about two-ninths share of the global market, and is expected to 
maintain this trend during the forecast period. This is due to high 
prevalence of diseases coupled with the advantages of consuming tablets 
and provision of accurate dosage level for different patient type.
Geography
North America dominated the Over the Counter 
(OTC) Drugs & Dietary Supplements Market. The 
market growth in North America is primarily a 
reflection of product innovations and launches 
resulting from technological advancements. The 
companies mostly adopted product launch, 
acquisition, and expansion as their key strategies to 
keep pace with the changing demands of consumers 
and strengthen their market position.
Key Market Players
The key players operating in the global Over the Counter (OTC) Drugs & Dietary 
Supplements Market are 
• Pfizer Inc., 
• Novartis International AG., 
• Roche Holding AG, 
• Merck & Co., Inc., 
• Sanofi S.A, 
• Johnson & Johnson, 
• Gilead Sciences, 
• GlaxoSmithKline plc., 
• Bayer Healthcare AG, 
• AstraZeneca plc.
The other players in the value chain of the global market include Allergan, Plc., Reckitt 
Benckiser Plc., AbbVie Inc., Sun Pharma, Daiichi Sankyo Co., Ltd., Alcon Inc., Alfresa Pharma 
Corporation, Alkalon A/S, Alliance Healthcare, and Allergan, Plc.
• An in-depth market analysis includes analysis of various 
Key Findings of the regions, which is anticipated to provide a detailed 
Over the Counter understanding of the current trends to enable 
stakeholders formulate region-specific plans.
(OTC) Drugs & • A comprehensive analysis of factors that drive and 
Dietary Supplements restrain the growth of the global is provided.
Market: • The projections in this report are made by analyzing the 
current trends and future market potential from 2021 to 
2030, in terms of value.
Find out more at the Allied Market Report store
https://www.alliedmarketresearch.com/over-the-counter-OTC-drugs-and-dietary-supplements-market
ABOUT ALLIED MARKET RESEARCH
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in 
Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched 
quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business 
insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their 
respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us 
generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented 
in the reports published by us is extracted through primary interviews with top officials from leading companies of domain 
concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with 
knowledgeable professionals and analysts in the industry.
Contact:  
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com